MAUDE Adverse Event Report: BECTON DICKINSON & CO. (SPARKS) BD BBL¿ GRAM SAFRANIN; STAINS, MICROBIOLOGIC

Catalog Number	212531
Medical Device Problem Code	Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	01/07/2026
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
Event or Problem Description
It was reported while using one (1) bd bbl¿ gram safranin, there were artifacts visible in the slide, rendering the stain unusable.User reports the appearance of the artifacts appeared similar to gram positive cocci.There was no health impact or consequence reported.
Event or Problem Description
It was reported while using one (1) bd bbl¿ gram safranin, there were artifacts visible in the slide, rendering the stain unusable.User reports the appearance of the artifacts appeared similar to gram positive cocci.There was no health impact or consequence reported.
Additional Manufacturer Narrative
Investigation summary - this memo is to summarize findings on your complaint related to bottle gram safranin 250ml, catalog number 212531, batch number 4242097, complaint # (b)(4), for unsatisfactory performance.Components are mixed and dispensed into the appropriate containers.After qc testing product is released and transported to the distribution center.The complaint investigation included a batch history review of gram crystal violet.The batch history record review indicated no discrepancies.All release testing was satisfactory.Complaint trends were reviewed for a period covering 12 months.During that time there have been no confirmed complaints for the defect in question for this product.One photo was received.The photo depicts a microscopic view of gram-negative culture and two dark purple nonbacterial artifacts.Return was received on 02/26/26 after testing was completed.Package was received damaged and spilled with mixed materials.Content inside now mixed materials and can be contaminated.No further testing can be conducted this time a retention sample from the complaint batch of gram safranin was evaluated along with a control batch.Staining was completed per instructions in the product insert.Slides of e.Coli atcc 25922 and s.Aureus atcc 25923 controls were evaluated and had satisfactory staining results for the retention and control batches.The retention sample was comparable to the control.This complaint cannot be confirmed.Waters will continue to trend dcm complaints for unsatisfactory performance.

• Brand Name: BD BBL¿ GRAM SAFRANIN
• Common Device Name: STAINS, MICROBIOLOGIC
• Manufacturer (Section D): BECTON DICKINSON & CO. (SPARKS); 7 loveton circle; sparks MD 21152
• Manufacturer (Section G): BECTON, DICKINSON & CO. (SPARKS); 7 loveton circle; sparks MD 21152
• Manufacturer Contact: matt j. connor ; 7 loveton circle; sparks, MD 21152 ; 4103164000
• MDR Report Key: 24168079
• Report Number: 1119779-2026-00024
• Device Sequence Number: 13011952
• Product Code: JTS
• UDI-Device Identifier: 30382902125311
• UDI-Public: (01)30382902125311(10)4207114
• Combination Product (Y/N): N
• Initial Reporter Country: SN
• PMA/510(K) Number: NA
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Other,Foreign,Company Representative
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 03/03/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Other
• Device Expiration Date: 03/31/2026
• Device Catalogue Number: 212531
• Device Lot Number: 4242097
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 01/07/2026
• Supplement Date Received by Manufacturer: 03/03/2026
• Initial Report FDA Received Date: 01/23/2026
• Supplement Report FDA Received Date: 03/06/2026
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 08/29/2024
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Patient Sex: Unknown